Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-20Clinical Trial Update: The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease [NA]
A completed trial evaluating Molecular Breast Imaging (MBI) for distinguishing benign from malignant breast disease, with results posted in …
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: The Efficacy and Safety of PEG-rhG-CSF in Neutropenia After Chemotherapy [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of PEG-rhG-CSF for neutropenia after chemotherapy in patients with breast c…
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors [Phase 1]
A Phase 1 pilot study evaluating the combination of sorafenib and bi-weekly capecitabine in patients with metastatic breast cancer and gastr…
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Gamma-delta Tocotrienol as Potential Maintenance Treatment in Women With Metastatic Breast Cancer [Phase 1]
Phase 1 trial update on gamma-delta tocotrienol as maintenance treatment in women with metastatic breast cancer, now completed.
-
CLINICAL_TRIALS trial_result · 2016-09-14Clinical Trial Update: Evaluation of Homeopathic Treatment for Hot Flashes in Non Metastatic Breast Cancer [Phase 3]
A Phase 3 trial evaluating homeopathic treatment for hot flashes in non-metastatic breast cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Non-Metastatic, Post Menopausal Breast Cancer Patients
This ClinicalTrials.gov entry reports a completed study evaluating musculoskeletal symptoms linked to aromatase inhibitors in non-metastatic…
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers [Phase 1]
Phase 1 study evaluating MM-121 in combination with paclitaxel in patients with advanced gynecologic cancers and HER2-non-overexpressing bre…
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer [Phase 2]
Phase 2 study comparing dose-dense docetaxel given before versus after standard doxorubicin/cyclophosphamide in axillary node-positive breas…
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer [Phase 3]
A Phase 3 trial investigating alternating cycles of doxorubicin/cyclophosphamide and docetaxel for metastatic breast cancer; the study statu…
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Study of ExAblate Focused Ultrasound Ablation of Breast Cancer [Phase 2]
A Phase 2 study evaluating ExAblate focused ultrasound ablation for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Capecitabine and Bevacizumab ± Vinorelbine in Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating capecitabine and bevacizumab with or without vinorelbine in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Preoperative Cisplatin in Early Stage Breast Cancer [Phase 2]
This is a Phase 2 clinical trial update evaluating preoperative cisplatin in patients with early-stage breast cancer.
-
CLINICAL_TRIALS trial_result · 2016-08-26Clinical Trial Update: Trial of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer [Phase 2]
A Phase 2 trial comparing neoadjuvant eribulin/cyclophosphamide versus docetaxel/cyclophosphamide in locally advanced HER2-negative breast c…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Phase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast Cancer [Phase 2]
Phase II neoadjuvant trial in breast cancer evaluating weekly nab-paclitaxel (Abraxane) with carboplatin and bevacizumab; the study (NCT0067…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: Effect Aerobic Training on Women With Breast Cancer After Chemotherapy [Phase 1]
Phase 1 trial assessing the effects of aerobic training on women with breast cancer after chemotherapy, including changes in hemoglobin leve…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of ZD6474 (vandetanib) in patients with metastatic breast cancer. The study is com…
-
CLINICAL_TRIALS trial_result · 2016-08-23Clinical Trial Update: Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer [Phase 3]
This Phase 3 trial evaluated tamoxifen citrate or letrozole with or without bevacizumab in women with stage IIIB or stage IV breast cancer; …
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer [Phase 2]
Phase 2 trial evaluating chemotherapy and radiation before surgery for triple-negative breast cancer was terminated; results were posted in …
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Increasing Adherence to Follow-up of Breast Abnormalities in Low-Income Korean American Women [NA]
A completed clinical trial update on strategies to increase adherence to follow-up for breast abnormalities among low-income Korean American…
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer
This completed observational study assessed Xeloda (capecitabine) in combination with docetaxel as first-line therapy for HER2-negative meta…
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Breast Cancer Screening Intervention [NA]
Clinical trial update shows a breast cancer screening intervention sponsored by the Jonsson Comprehensive Cancer Center has completed. The s…
-
CLINICAL_TRIALS trial_result · 2016-08-17Clinical Trial Update: Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast Cancer [Phase 2, Phase 3]
This clinical trial update reports on Phase 2 and Phase 3 studies evaluating trastuzumab given concurrently or sequentially with anthracycli…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: ROLL vs WGLL for Non-palpable Breast Lesions [Phase 2]
A Phase 2 trial comparing ROLL and WGLL for localization of non-palpable breast lesions in breast cancer was completed.
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: Developing Plasma DNA as a Surrogate for Tumor Biopsy to Identify Tumor Genetic Alterations in Patients With Advanced Breast Cancer
The clinical trial evaluating plasma DNA as a surrogate for tumor biopsy to identify tumor genetic alterations in advanced breast cancer has…
-
CLINICAL_TRIALS trial_result · 2016-08-16Clinical Trial Update: Effect of a Goal Setting Intervention on Exercise in Women With Metastatic Breast Cancer: An Exploration of The Lipogenic Pathway [NA]
The clinical trial evaluating a goal-setting intervention to improve exercise in women with metastatic breast cancer was terminated; the upd…